The rise of more transparent, “Cost Plus” pharmacy models is stirring debate within the pharmaceutical space as smaller players put pressure on the large PBMs.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
UPMC pharmacy leader: 'Cost Plus' models threaten PBMs
